ZN-B-2262

N/A

Report date: 2024/07/04 18:02:50
NME

Base Information

Drug NameZN-B-2262
Drug Alias NameZN-B-2262
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATM inhibitors
TargetsSerine-protein kinase ATM
Therapy Area/IndicationsSolid tumoursHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Zanrong Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Zanrong Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A